topic

  • Lung complications of prescription drug abuse
    Josiah D. McCain, MD, Monia E. Werlang, MD, Andras Khoor, MD, PhD and Isabel Mira-Avendano, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 910-911; DOI: https://doi.org/10.3949/ccjm.85a.18050

    Opioid tablets crushed, then injected intravenously.

  • Acute necrotizing esophagitis
    Takeshi Kondo, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 912-913; DOI: https://doi.org/10.3949/ccjm.85a.18054

    Poorly controlled diabetes, confusion, coffee-ground emesis.

  • Men’s health 2018 (November 2018)
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 913;

    An error occurred in Chaitoff A, Killeen TC, Nielsen C. Men’s health 2018: BPH, prostate cancer, erectile dysfunction, supplements. Cleve Clin J Med 2018; 85(11):871–880. doi:10.3949/ccjm.85a.18011.

  • What can I do when first-line measures are not enough for vasovagal syncope?
    Erika Hutt-Centeno, MD and Kenneth A. Mayuga, MD, FHRS, FACC, FACP
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 920-922; DOI: https://doi.org/10.3949/ccjm.85a.17112

    Second-line measures include midodrine, fludrocortisone, beta-blockers, and SSRIs, but evidence is limited.

  • Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?
    Gregory T. Brennan, MD, Alex Duong, Emily T. Nguyen, PharmD and Douglas L. Nguyen, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 923-924; DOI: https://doi.org/10.3949/ccjm.85a.18037

    Active IBD poses a greater risk than continuing drug therapy.

  • Do all hospital inpatients need cardiac telemetry?
    Motaz Baibars, MD, Yasser Al-Khadra, MD, Zaher Fanari, MD, Homam Moussa Pacha, MD, Mohamad Soud, MD and M. Chadi Alraies, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 925-927; DOI: https://doi.org/10.3949/ccjm.85a.17114

    Routine cardiac telemetry raises costs and does little.

  • Our missing microbes: Short-term antibiotic courses have long-term consequences
    Martin J. Blaser, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 928-930; DOI: https://doi.org/10.3949/ccjm.85gr.18005

    Is the rise in chronic diseases due to loss of microbial diversity?

  • Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Beta-cell therapies for type 1 diabetes: Transplants and bionics
    Kathryn Bux Rodeman, MD and Betul Hatipoglu, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 931-937; DOI: https://doi.org/10.3949/ccjm.85a.17088

    Chief among the challenges: millions of people have diabetes.

  • Telemedicine: Past, present, and future
    Jamal H. Mahar, MD, Gregory J. Rosencrance, MD and Peter A. Rasmussen, MD
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 938-942; DOI: https://doi.org/10.3949/ccjm.85a.17062

    Low reimbursement, licensing, practice issues limit its use.

  • Cannabis for peripheral neuropathy: The good, the bad, and the unknown
    Vania Modesto-Lowe, MD, MPH, Rachel Bojka, MS, PA-C and Camille Alvarado, DO, MPH
    Cleveland Clinic Journal of Medicine December 2018, 85 (12) 943-949; DOI: https://doi.org/10.3949/ccjm.85a.17115

    Even where it is legal, doctors should recommend it only after careful consideration.

Pages